Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/1267
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Upadhyay, Pramod | - |
dc.contributor.author | Agarwal, Manisha | - |
dc.contributor.author | Gupta, Chanda | - |
dc.contributor.author | Mohan, K Varsha | - |
dc.contributor.author | Jha, Vivek | - |
dc.date.accessioned | 2022-02-03T04:42:18Z | - |
dc.date.available | 2022-02-03T04:42:18Z | - |
dc.date.issued | 2020-09 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/1267 | - |
dc.description | Case Report | en_US |
dc.description.abstract | Tubercular granulomas are a common manifestation of intraocular tuberculosis. These are said to be hypoxic granulomas with increased expression of vascular endothelial growth factor (VEGF). Management of these granulomas includes a combination of antitubercular therapy (ATT) and oral corticosteroids. We report a case of tubercular granuloma with exudative retinal detachment which was treated with weekly intravitreal anti-VEGF and antibiotic injections along with ATT and corticosteroids. The VEGF levels measured paralleled with the clinical regression of the granuloma. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer – Medknow | en_US |
dc.subject | Anti-VEGF drug; VEGF; bevacizumab; tubercular granuloma; vascular endothelial growth factor. | en_US |
dc.title | Correlation of vascular endothelial growth factor with the clinical regression of tubercular granuloma | en_US |
dc.type | Other | en_US |
dc.journal | Indian J Ophthalmol | en_US |
dc.volumeno | 68 | en_US |
dc.issueno | 9 | en_US |
dc.pages | 2037-2040 | en_US |
Appears in Collections: | Product Development Cell - I, Publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Correlation_of_vascular_endothelial_growth_factor.92.pdf | 1.45 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.